Solomon Moshkevich, president of Clinical Diagnostics, sold Natera Inc. ($NTRA) shares on the open market 62 times over the past year, totaling about $16 million. His most recent sale occurred on March 10, 2026. These transactions rank him 798th among nearly 12,000 insiders by sale value, well above the average of $8.6 million across about six sales per insider. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 915 | $204.13 | 150,882.0000 | 136,721,000 | 0.60% | 0.00% |
| March 9, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 1774 | $0.00 | 151,797.0000 | 136,721,000 | 1.18% | 0.00% |
| March 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | M | Common Stock | 5125 | $9.59 | 153,023.0000 | 136,721,000 | 3.47% | 0.00% |
| March 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 931 | $198.83 | 152,092.0000 | 136,721,000 | 0.61% | 0.00% |
| March 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1594 | $200.11 | 150,498.0000 | 136,721,000 | 1.05% | 0.00% |
| March 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 475 | $200.97 | 150,023.0000 | 136,721,000 | 0.32% | 0.00% |
| March 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | M | Stock Option (right to buy) | 5125 | $0.00 | 0.0000 | 136,721,000 | 100.00% | 0.00% |
| Feb. 27, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 10051 | $0.00 | 147,898.0000 | 136,721,000 | 7.29% | 0.01% |
| Feb. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 878 | $229.96 | 141,528.0000 | 136,721,000 | 0.62% | 0.00% |
| Feb. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 80 | $228.50 | 142,406.0000 | 136,721,000 | 0.06% | 0.00% |
| Feb. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 576 | $230.84 | 140,952.0000 | 136,721,000 | 0.41% | 0.00% |
| Feb. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 850 | $232.33 | 140,102.0000 | 136,721,000 | 0.60% | 0.00% |
| Feb. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 600 | $233.24 | 139,502.0000 | 136,721,000 | 0.43% | 0.00% |
| Feb. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 16 | $234.00 | 139,486.0000 | 136,721,000 | 0.01% | 0.00% |
| Feb. 3, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1639 | $230.77 | 137,847.0000 | 136,721,000 | 1.18% | 0.00% |
| Jan. 27, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1013 | $240.53 | 143,686.0000 | 136,721,000 | 0.70% | 0.00% |
| Jan. 28, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1200 | $237.66 | 142,486.0000 | 136,721,000 | 0.84% | 0.00% |
| Jan. 21, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 293 | $235.00 | 144,699.0000 | 136,721,000 | 0.20% | 0.00% |
| Jan. 20, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 23205 | $234.74 | 144,992.0000 | 136,721,000 | 13.80% | 0.02% |
| Jan. 14, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 44698 | $0.00 | 168,197.0000 | 136,721,000 | 36.19% | 0.03% |
| Jan. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1659 | $229.43 | 123,499.0000 | 136,721,000 | 1.33% | 0.00% |
| Jan. 2, 2026 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1292 | $228.33 | 125,158.0000 | 136,721,000 | 1.02% | 0.00% |
| Dec. 10, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | M | Stock Option (right to buy) | 22376 | $0.00 | 5,125.0000 | 137,187,000 | 81.36% | 0.02% |
| Dec. 15, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | G | Common Stock | 115 | $0.00 | 126,450.0000 | 137,187,000 | 0.09% | 0.00% |
| Dec. 12, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | M | Common Stock | 13500 | $9.59 | 126,565.0000 | 137,187,000 | 11.94% | 0.01% |
| Dec. 12, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 4692 | $230.76 | 113,065.0000 | 137,187,000 | 3.98% | 0.00% |
| Dec. 12, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | M | Common Stock | 8876 | $9.59 | 117,757.0000 | 137,187,000 | 8.15% | 0.01% |
| Dec. 12, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | G | Common Stock | 180 | $0.00 | 108,881.0000 | 137,187,000 | 0.17% | 0.00% |
| Dec. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 474 | $239.53 | 109,061.0000 | 137,187,000 | 0.43% | 0.00% |
| Dec. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1527 | $238.24 | 109,535.0000 | 137,187,000 | 1.37% | 0.00% |
| Dec. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 250 | $237.77 | 111,062.0000 | 137,187,000 | 0.22% | 0.00% |
| Dec. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 749 | $237.23 | 111,312.0000 | 137,187,000 | 0.67% | 0.00% |
| Nov. 3, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1450 | $199.10 | 112,161.0000 | 137,187,000 | 1.28% | 0.00% |
| Nov. 3, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 100 | $199.74 | 112,061.0000 | 137,187,000 | 0.09% | 0.00% |
| Nov. 3, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1450 | $198.03 | 113,611.0000 | 137,187,000 | 1.26% | 0.00% |
| Oct. 27, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1008 | $192.32 | 116,259.0000 | 137,187,000 | 0.86% | 0.00% |
| Oct. 28, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1198 | $191.46 | 115,061.0000 | 137,187,000 | 1.03% | 0.00% |
| Oct. 21, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 292 | $187.95 | 117,267.0000 | 137,187,000 | 0.25% | 0.00% |
| Oct. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 404 | $158.96 | 120,155.0000 | 137,187,000 | 0.34% | 0.00% |
| Oct. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 780 | $160.70 | 117,559.0000 | 137,187,000 | 0.66% | 0.00% |
| Oct. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1816 | $159.91 | 118,339.0000 | 137,187,000 | 1.51% | 0.00% |
| Sept. 15, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | G | Common Stock | 300 | $0.00 | 120,559.0000 | 136,388,000 | 0.25% | 0.00% |
| Sept. 2, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1210 | $167.71 | 120,859.0000 | 136,388,000 | 0.99% | 0.00% |
| Sept. 2, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1290 | $165.69 | 122,569.0000 | 136,388,000 | 1.04% | 0.00% |
| Sept. 2, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 500 | $166.39 | 122,069.0000 | 136,388,000 | 0.41% | 0.00% |
| Aug. 12, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 1675 | $0.00 | 124,734.0000 | 136,388,000 | 1.36% | 0.00% |
| Aug. 14, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 867 | $155.46 | 123,867.0000 | 136,388,000 | 0.70% | 0.00% |
| Aug. 14, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 8 | $155.42 | 123,859.0000 | 136,388,000 | 0.01% | 0.00% |
| Aug. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 100 | $134.08 | 123,059.0000 | 136,388,000 | 0.08% | 0.00% |
| Aug. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1574 | $132.45 | 124,485.0000 | 136,388,000 | 1.25% | 0.00% |
| Aug. 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1326 | $133.31 | 123,159.0000 | 136,388,000 | 1.07% | 0.00% |
| July 28, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 2206 | $139.81 | 126,059.0000 | 136,388,000 | 1.72% | 0.00% |
| July 21, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 291 | $139.29 | 128,265.0000 | 136,388,000 | 0.23% | 0.00% |
| May 27, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1649 | $156.85 | 128,556.0000 | 134,750,000 | 1.27% | 0.00% |
| July 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 291 | $167.79 | 130,205.0000 | 136,388,000 | 0.22% | 0.00% |
| July 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 2109 | $167.25 | 130,496.0000 | 136,388,000 | 1.59% | 0.00% |
| July 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 400 | $163.88 | 132,805.0000 | 136,388,000 | 0.30% | 0.00% |
| July 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 200 | $165.99 | 132,605.0000 | 136,388,000 | 0.15% | 0.00% |
| June 2, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 465 | $158.37 | 133,305.0000 | 134,750,000 | 0.35% | 0.00% |
| June 2, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1290 | $156.30 | 134,915.0000 | 134,750,000 | 0.95% | 0.00% |
| June 2, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1145 | $157.23 | 133,770.0000 | 134,750,000 | 0.85% | 0.00% |
| June 2, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 100 | $159.12 | 133,205.0000 | 134,750,000 | 0.08% | 0.00% |
| May 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 853 | $148.25 | 138,352.0000 | 134,750,000 | 0.61% | 0.00% |
| May 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 908 | $149.99 | 137,444.0000 | 134,750,000 | 0.66% | 0.00% |
| May 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 908 | $151.30 | 136,536.0000 | 134,750,000 | 0.66% | 0.00% |
| May 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 331 | $152.04 | 136,205.0000 | 134,750,000 | 0.24% | 0.00% |
| April 28, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | G | Common Stock | 75 | $0.00 | 139,205.0000 | 134,750,000 | 0.05% | 0.00% |
| April 28, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 2206 | $152.18 | 139,280.0000 | 134,750,000 | 1.56% | 0.00% |
| April 21, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 292 | $145.54 | 141,490.0000 | 134,750,000 | 0.21% | 0.00% |
| April 21, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 4 | $146.85 | 141,486.0000 | 134,750,000 | 0.00% | 0.00% |
| April 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1270 | $140.70 | 142,221.0000 | 134,750,000 | 0.89% | 0.00% |
| April 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1291 | $139.78 | 143,491.0000 | 134,750,000 | 0.89% | 0.00% |
| April 1, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 439 | $141.90 | 141,782.0000 | 134,750,000 | 0.31% | 0.00% |
| March 17, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 3 | $149.74 | 144,782.0000 | 124,718,000 | 0.00% | 0.00% |
| March 17, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1023 | $146.03 | 144,785.0000 | 124,718,000 | 0.70% | 0.00% |
| March 12, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 2040 | $0.00 | 145,808.0000 | 124,718,000 | 1.42% | 0.00% |
| March 5, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1700 | $144.12 | 144,168.0000 | 124,718,000 | 1.17% | 0.00% |
| March 5, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1200 | $142.08 | 148,568.0000 | 124,718,000 | 0.80% | 0.00% |
| March 5, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 2700 | $143.05 | 145,868.0000 | 124,718,000 | 1.82% | 0.00% |
| March 5, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 400 | $144.97 | 143,768.0000 | 124,718,000 | 0.28% | 0.00% |
| Feb. 6, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1632 | $177.77 | 149,768.0000 | 124,718,000 | 1.08% | 0.00% |
| Feb. 5, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 1675 | $0.00 | 149,878.0000 | 124,718,000 | 1.13% | 0.00% |
| Feb. 5, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 1522 | $0.00 | 151,400.0000 | 124,718,000 | 1.02% | 0.00% |
| Jan. 31, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 12720 | $0.00 | 148,203.0000 | 124,718,000 | 9.39% | 0.01% |
| Jan. 29, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 4020 | $165.87 | 135,486.0000 | 124,718,000 | 2.88% | 0.00% |
| Jan. 29, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1178 | $165.87 | 139,056.0000 | 124,718,000 | 0.84% | 0.00% |
| Jan. 29, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 3 | $167.36 | 135,483.0000 | 124,718,000 | 0.00% | 0.00% |
| Jan. 22, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 24799 | $164.95 | 140,746.0000 | 124,718,000 | 14.98% | 0.02% |
| Jan. 22, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 62 | $171.95 | 140,684.0000 | 124,718,000 | 0.04% | 0.00% |
| Jan. 16, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 9620 | $0.00 | 165,545.0000 | 124,718,000 | 6.17% | 0.01% |
| Jan. 16, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 29798 | $0.00 | 155,925.0000 | 124,718,000 | 23.63% | 0.02% |
| Jan. 16, 2025 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 9130 | $0.00 | 126,127.0000 | 124,718,000 | 7.80% | 0.01% |
| Dec. 23, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 2 | $158.06 | 119,423.0000 | 123,775,000 | 0.00% | 0.00% |
| Dec. 20, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 1675 | $0.00 | 116,381.0000 | 123,775,000 | 1.46% | 0.00% |
| Dec. 20, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 3044 | $0.00 | 119,425.0000 | 123,775,000 | 2.62% | 0.00% |
| Dec. 23, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 3 | $158.19 | 119,420.0000 | 123,775,000 | 0.00% | 0.00% |
| Dec. 23, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 2423 | $159.60 | 116,997.0000 | 123,775,000 | 2.03% | 0.00% |
| Dec. 23, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | G | Common Stock | 81 | $0.00 | 114,706.0000 | 123,775,000 | 0.07% | 0.00% |
| Dec. 19, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | G | Common Stock | 125 | $0.00 | 114,787.0000 | 123,775,000 | 0.11% | 0.00% |
| Dec. 9, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | M | Stock Option (right to buy) | 3323 | $0.00 | 0.0000 | 123,775,000 | 100.00% | 0.00% |
| Dec. 9, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 5752 | $7.45 | 116,447.0000 | 123,775,000 | 5.20% | 0.00% |
| Dec. 9, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 3323 | $12.85 | 119,770.0000 | 123,775,000 | 2.85% | 0.00% |
| Dec. 9, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 4858 | $166.59 | 114,912.0000 | 123,775,000 | 4.06% | 0.00% |
| Dec. 9, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | M | Stock Option (right to buy) | 5752 | $0.00 | 0.0000 | 123,775,000 | 100.00% | 0.00% |
| Oct. 28, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1196 | $118.21 | 110,695.0000 | 123,775,000 | 1.07% | 0.00% |
| Oct. 21, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 294 | $120.76 | 112,147.0000 | 123,775,000 | 0.26% | 0.00% |
| Oct. 22, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 256 | $120.07 | 111,891.0000 | 123,775,000 | 0.23% | 0.00% |
| July 29, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1196 | $102.77 | 112,441.0000 | 122,853,000 | 1.05% | 0.00% |
| July 22, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 549 | $105.16 | 113,637.0000 | 122,853,000 | 0.48% | 0.00% |
| May 28, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1647 | $109.96 | 114,186.0000 | 120,814,000 | 1.42% | 0.00% |
| April 29, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 1196 | $93.14 | 115,833.0000 | 120,814,000 | 1.02% | 0.00% |
| April 23, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 531 | $91.38 | 117,029.0000 | 120,814,000 | 0.45% | 0.00% |
| April 16, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 53489 | $91.06 | 117,560.0000 | 120,814,000 | 31.27% | 0.04% |
| April 16, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 26511 | $90.34 | 171,049.0000 | 120,814,000 | 13.42% | 0.02% |
| March 28, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 707 | $90.42 | 197,560.0000 | 114,997,000 | 0.36% | 0.00% |
| Feb. 29, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 3206 | $0.00 | 200,512.0000 | 114,997,000 | 1.62% | 0.00% |
| March 5, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 18 | $87.33 | 200,494.0000 | 114,997,000 | 0.01% | 0.00% |
| March 5, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 2227 | $88.37 | 198,267.0000 | 114,997,000 | 1.11% | 0.00% |
| March 1, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 2329 | $0.00 | 197,306.0000 | 114,997,000 | 1.19% | 0.00% |
| Jan. 29, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | S | Common Stock | 3426 | $65.09 | 194,977.0000 | 114,997,000 | 1.73% | 0.00% |
| Jan. 26, 2024 | Natera, Inc. | $NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | A | Common Stock | 31352 | $0.00 | 198,403.0000 | 114,997,000 | 18.77% | 0.03% |